Aratana Therapeutics Offers Update on Monoclonal Antibody Products By: Benzinga via Benzinga July 22, 2015 at 09:19 AM EDT Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of ... Read More >> Related Stocks: Aratana Theraptcs